CONTACT US
CONTACT US
CONTACT US

DA VINCI® SINGLE-SITE HYSTERECTOMY (BENIGN)

  • Home
  • DA VINCI® SINGLE-SITE HYSTERECTOMY (BENIGN)

One of the most important things to do before your hysterectomy is to learn about the types of surgeries available today. There are more ways to have your uterus removed than ever before.

Know Your Hysterectomy Options

If your doctor suggests a hysterectomy, the most common ways to remove your uterus are: open surgery and minimally invasive surgery (traditional laparoscopy or robotically-assisted da Vinci Surgery).

Why da Vinci Surgery?

When using da Vinci Single-Site* Surgery for benign (not cancer), your surgeon operates through a small cut in your belly button*. Patients see almost scarless results, like single incision traditional laparoscopy.

Early clinical data suggests da Vinci Single-Site Hysterectomy offers the following potential benefits:

  • Low blood loss 1,2,3,4
  • Low rate of complications 1,2
  • Low chance of a blood transfusion 2
  • Low chance of surgeon switching to open surgery 2,3,4
  • Short hospital stay 2,3
  • Low level of post-operative pain 4

The da Vinci System has brought minimally invasive surgery to more than 3 million patients worldwide. da Vinci technology – changing the experience of surgery for people around the world.

* Single-Site technology is only available for benign (non-cancerous) conditions.

Risks & Considerations Related to Hysterectomy, Benign (removal of the uterus and possibly nearby organs): injury to the ureters (ureters drain urine from the kidney into the bladder), vaginal cuff problems (scar tissue in vaginal incision, infection, bacterial skin infection, pooling/clotting of blood, incision opens or separates), injury to bladder (organ that holds urine), bowel injury, vaginal shortening, problems urinating (cannot empty bladder, urgent or frequent need to urinate, leaking urine, slow or weak stream), abnormal hole from the vagina into the urinary tract or rectum, vaginal tear or deep cut. Uterine tissue may contain unsuspected cancer. The cutting or morcellation of uterine tissue during surgery may spread cancer, and decrease the long-term survival of patients.

1. Cela V, Freschi L, Simi G, Ruggiero M, Tana R, Pluchino N. "Robotic single-site hysterectomy: feasibility, learning curve and surgical outcome." Surg Endosc. 2013 Jul;27(7):2638-43. doi: 10.1007/s00464-012-2780-8. Epub 2013 Feb 8.
2. Akdemir A, Zeybek B, Ozgurel B, Oztekin MK, Sendag F. "Learning curve analysis of intracorporeal cuff suturing during robotic single-site total hysterectomy." J Minim Invasive Gynecol. 2015 Mar-Apr;22(3):384-9. doi: 10.1016/j.jmig.2014.06.006. Epub 2014 Jun 19.
3. Scheib SA, Fader AN. "Gynecologic robotic laparoendoscopic single-site surgery: prospective analysis of feasibility, safety, and technique." Am J Obstet Gynecol. 2015 Feb;212(2):179.e1-8. doi: 10.1016/j.ajog.2014.07.057. Epub 2014 Aug 1.
4. Bogliolo S, Mereu L, Cassani C, Gardella B, Zanellini F, Dominoni M, Babilonti L, Delpezzo C, Tateo S, Spinillo A. "Robotic single-site hysterectomy: two institutions' preliminary experience." Int J Med Robot. 2014 Sep 18. doi: 10.1002/rcs.1613. [Epub ahead of print]

© AIMIS HEALTHCARE GROUP 2021 All Rights Reserved.